Clinical and health technology experts from Wolters Kluwer Health are heading to HLTH 2024 from October 20-23 to share how emerging applications like artificial intelligence (AI) and enterprise data analytics are reimagining clinical workflows today and into the future. At booths #3219, and #4108 in the AI @ HLTH Pavilion, the company will offer live demonstrations showcasing how it helps healthcare organizations navigate trends in consumer behavior, innovation, and workforce dynamics to deliver the best care everywhere.
From applying AI in care delivery and personalizing care engagement in traditional and nontraditional care settings like retail pharmacies, to leveraging enterprise analytics, these demonstrations will highlight the company’s approach to unlocking value across the care continuum.
“Our commitment to advancing healthcare innovation is rooted in the belief that advanced technologies like generative AI (GenAI) must be seamlessly and responsibly integrated into clinical workflows to truly enhance patient care,” said Greg Samios, President and CEO of Clinical Effectiveness for Wolters Kluwer Health. “At HLTH 2024, we will make it clear that we are not only fueling next-generation clinical decision support and responsible AI use with our collaborations and underlying content, but also empowering patients and clinicians and healthcare decision makers across all settings with the tools to help deliver superior experiences and outcomes.”
Wolters Kluwer Health’s experts and customers will showcase the following topics at the AI @ HLTH Pavilion and the company’s booths:
Collaborations to Advance the Responsible Use of AI
Wolters Kluwer Health is joining the Coalition for Health AI (CHAI) to help deploy safe and effective AI in patient care and will participate in the inaugural CHAI Global Summit on October 19-20 at HLTH. CHAI is a private-sector coalition committed to developing industry best practices and frameworks to address the urgent need for independent validation for quality assurance, representation, and ethical practices for health AI.
Additionally, through AI Labs, Wolters Kluwer Health is working together with customers to rigorously test an array of AI applications in the clinical decision support context. AI Labs allows for experimentation and testing of capabilities and represents a new era of clinical decision support.
As outlined in a new whitepaper, the future of Generative AI in healthcare is founded on trusted and expert content. Responsible innovation and transparency are key to finding balance between the urgency to evolve and the need to ensure patient safety. AI Labs focuses on validating that advanced capabilities are rigorously tested before introducing them in trusted resources like UpToDate, which more than two million clinicians rely on for clinical decision support and evidence-based content to assist in care decisions.
Wolters Kluwer Health will also discuss their recently announced collaborations with Wellsheet and Abridge to bring UpToDate closer to clinicians in the workflow.
Consumer-Driven Healthcare
Matt Sullivan, Associate Director, Clinical Effectiveness Product Management, Wolters Kluwer Health, will present on the Tech Talk stage on Monday, October 21, from 1:55 to 2:15 p.m. PDT about delivering consumer-driven experiences. Sullivan will address how to personalize healthcare experiences grounded in data and convenience, empowering patients to take ownership of their healthcare with Wolters Kluwer’s Digital Medication Education and Consumer Education suites by UpToDate Digital Architect.
Generative AI and Care Delivery
On Tuesday, October 22, from 2:45 to 3:05 p.m. PDT in the AI @ HLTH Pavilion, Sheila Bond, MD, Director Clinical Content, Wolters Kluwer Health, and Dick Taylor, MD, Chief Clinical Informatics Officer at Washington University and BJC Healthcare, will present on “Generative AI: How Care Delivery Got Left Behind.”
With GenAI not yet fully deployed and embraced in clinical patient care, Drs. Bond and Taylor will present ideas on unlocking AI’s full potential in care delivery. They will share the lessons they have learned from experimenting with GenAI’s potential in patient care and discuss how to overcome concerns about the reliability of AI-generated clinical guidance and the underlying content sets training these capabilities.
To learn more, schedule an individual briefing or demo at HLTH. For more information about Wolters Kluwer, please visit: www.wolterskluwer.com.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241014567735/en/